SI1646659T1 - Postopek za pripravo spojin 1,3-propan disulfonske kisline - Google Patents
Postopek za pripravo spojin 1,3-propan disulfonske kislineInfo
- Publication number
- SI1646659T1 SI1646659T1 SI200432160T SI200432160T SI1646659T1 SI 1646659 T1 SI1646659 T1 SI 1646659T1 SI 200432160 T SI200432160 T SI 200432160T SI 200432160 T SI200432160 T SI 200432160T SI 1646659 T1 SI1646659 T1 SI 1646659T1
- Authority
- SI
- Slovenia
- Prior art keywords
- preparation
- acid compounds
- disulfonic acid
- propane disulfonic
- propane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/05—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing at least two sulfo groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48090603P | 2003-06-23 | 2003-06-23 | |
US48205803P | 2003-06-23 | 2003-06-23 | |
US51204703P | 2003-10-17 | 2003-10-17 | |
US51213503P | 2003-10-17 | 2003-10-17 | |
US10/871,514 US7414076B2 (en) | 2003-06-23 | 2004-06-18 | Methods and compositions for treating amyloid-related diseases |
US10/871,543 US7253306B2 (en) | 2003-06-23 | 2004-06-18 | Pharmaceutical drug candidates and methods for preparation thereof |
EP04744203.3A EP1646659B1 (en) | 2003-06-23 | 2004-06-21 | Method for the preparation of 1,3-propane disulfonic acid compounds |
PCT/IB2004/002563 WO2004113391A2 (en) | 2003-06-23 | 2004-06-21 | Improved pharmaceutical drug candidates and methods for preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1646659T1 true SI1646659T1 (sl) | 2014-07-31 |
Family
ID=38987140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200432160T SI1646659T1 (sl) | 2003-06-23 | 2004-06-21 | Postopek za pripravo spojin 1,3-propan disulfonske kisline |
Country Status (7)
Country | Link |
---|---|
US (2) | US20080027097A1 (sl) |
JP (1) | JP2012176963A (sl) |
HK (1) | HK1090655A1 (sl) |
HR (1) | HRP20140442T1 (sl) |
IL (1) | IL172250A0 (sl) |
SI (1) | SI1646659T1 (sl) |
TW (1) | TW200517367A (sl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040208875A1 (en) * | 1995-03-15 | 2004-10-21 | Queen's University At Kingston | Method for treating amyloidosis |
AU5994900A (en) * | 1999-07-09 | 2001-01-30 | Isis Innovation Limited | Compounds for inhibiting diseases and preparing cells for transplantation |
US20070010573A1 (en) * | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
US7244764B2 (en) * | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
EP2797681B1 (en) * | 2011-12-29 | 2017-02-01 | Omrix Biopharmaceuticals Ltd. | Method and device for fast dissolution of solid protein composition |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2693488A (en) * | 1950-08-30 | 1954-11-02 | Dow Chemical Co | Purification of amino alkane sulfonic acids by ion exchange |
US3658966A (en) * | 1969-09-15 | 1972-04-25 | Kowa Co | Methods of treating hypertension |
US4085134A (en) * | 1974-02-15 | 1978-04-18 | Petrolite Corporation | Amino-phosphonic-sulfonic acids |
US5840294A (en) * | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
US5972328A (en) * | 1993-03-29 | 1999-10-26 | Queen's University At Kingston | Method for treating amyloidosis |
AU1143200A (en) * | 1998-11-10 | 2000-05-29 | Neurochem, Inc. | Polymorphic forms of an amyloidosis inhibitor and methods of preparation |
US6562836B1 (en) * | 1999-05-24 | 2003-05-13 | Queen's University Of Kingston | Methods and compounds for inhibiting amyloid deposits |
-
2004
- 2004-06-21 SI SI200432160T patent/SI1646659T1/sl unknown
- 2004-06-23 TW TW093118182A patent/TW200517367A/zh unknown
-
2005
- 2005-11-29 IL IL172250A patent/IL172250A0/en not_active IP Right Cessation
-
2006
- 2006-10-17 HK HK06111373.8A patent/HK1090655A1/xx not_active IP Right Cessation
-
2007
- 2007-07-11 US US11/776,407 patent/US20080027097A1/en not_active Abandoned
-
2010
- 2010-07-23 US US12/842,990 patent/US20110021813A1/en not_active Abandoned
-
2012
- 2012-05-02 JP JP2012104999A patent/JP2012176963A/ja active Pending
-
2014
- 2014-05-19 HR HRP20140442TT patent/HRP20140442T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
TW200517367A (en) | 2005-06-01 |
HK1090655A1 (en) | 2006-12-29 |
US20080027097A1 (en) | 2008-01-31 |
US20110021813A1 (en) | 2011-01-27 |
HRP20140442T1 (hr) | 2014-07-04 |
JP2012176963A (ja) | 2012-09-13 |
IL172250A0 (en) | 2006-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL377905A1 (pl) | 2,4-difluorowco-6-(C<v>2<D> -C<v>3<D> -alkilo)fenylo-podstawione pochodne kwasu tetramowego | |
SI1710241T1 (sl) | Intermediatne spojine za pripravo trans-5-kloro-2-metil-2,3,3a, 12b-tetrahidro-1H-dibenz(2,3:6,7)oksepino(4,5-C)pirola | |
IL173456A0 (en) | Process for the preparation of 4-amino-3-quinolinecarbonitriles | |
ZA200605864B (en) | Method for the production of methionine | |
HK1080477A1 (en) | Process for the preparation of pyrimidine compounds | |
IL183591A0 (en) | Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives | |
IL180311A0 (en) | Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters | |
HK1108580A1 (en) | A process for the preparation of [1,4,5]-oxadiazepine derivatives | |
IL172629A0 (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
IL175743A0 (en) | Process for the preparation of thiazolopyrimidines | |
PL374461A1 (pl) | Sposób otrzymywania pochodnych 13,14-dihydro-PGF | |
HK1090655A1 (en) | Method for the preparation of 1,3-propane disulfonic acid compounds 13- | |
AU2003241211A1 (en) | Method for the recovery of ferulic acid | |
EP1636176A4 (en) | POLYMORPHIC FORM OF 4-6-ACETYL-3- 3- (4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO) PROPOXY -2-PROPYLPHENOXY BUTYRIC ACID | |
HUP0600231A2 (en) | Novel process for the preparation of 2h-chromenes | |
EP1556400A4 (en) | PROCESS FOR THE PREPARATION OF 2-HALOGEN-2-DESOXYADENOSINE COMPOUNDS FROM 2-DESOXYGUANOSINE | |
EP1646640A4 (en) | PROCESS FOR PREPARING HIGH-PURITY 1-ANDROSTEN DERIVATIVES | |
IL165137A0 (en) | Process for the preparation of thioalkylamine derivatives | |
AU2003256102A1 (en) | Method for the selective preparation of 3-oxo-4-aza-5a-androstane compound | |
HK1095145A1 (en) | Process for the preparation of n-arylmorpholinones n- | |
PL1656340T3 (pl) | Sposoby wytwarzania pochodnych kwasu 1-karbamoilocykloalkilokarboksylowego | |
SG111997A1 (en) | Improved process for the preparation of polyalkylphenoxyaminoalkanes | |
IL186457A0 (en) | Process for the preparation of 9,10-dehydro-12,13-desoxyepothilone derivatives | |
AU2003224495A1 (en) | Process for the preparation of enantiomerically enriched compounds | |
AU2003269482A1 (en) | Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde |